Cargando…

Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy

Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gönç, E. Nazlı, Özön, Alev, Alikaşifoğlu, Ayfer, Kandemir, Nurgün
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596812/
https://www.ncbi.nlm.nih.gov/pubmed/28588004
http://dx.doi.org/10.4274/jcrpe.3986
_version_ 1783263606742188032
author Gönç, E. Nazlı
Özön, Alev
Alikaşifoğlu, Ayfer
Kandemir, Nurgün
author_facet Gönç, E. Nazlı
Özön, Alev
Alikaşifoğlu, Ayfer
Kandemir, Nurgün
author_sort Gönç, E. Nazlı
collection PubMed
description Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in this disorder. We herein present a girl with PC1/3 deficiency who has been followed from birth to 17 years of age. She developed deficiencies of all pituitary hormones over time as well as diabetes mellitus while receiving growth hormone (GH) therapy. She was complicated with diabetic ketoacidosis during dietary management of diabetes mellitus, thus insulin treatment was initiated. Insulin requirement to regulate hyperglycemia was short-lived. Repeat oral glucose tolerance test five years later was normal. The findings of this patient show that diabetes mellitus can develop at any time during follow-up of cases with proportein convertase 1/3 deficiency especially under GH therapy.
format Online
Article
Text
id pubmed-5596812
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-55968122017-09-18 Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy Gönç, E. Nazlı Özön, Alev Alikaşifoğlu, Ayfer Kandemir, Nurgün J Clin Res Pediatr Endocrinol Case Report Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in this disorder. We herein present a girl with PC1/3 deficiency who has been followed from birth to 17 years of age. She developed deficiencies of all pituitary hormones over time as well as diabetes mellitus while receiving growth hormone (GH) therapy. She was complicated with diabetic ketoacidosis during dietary management of diabetes mellitus, thus insulin treatment was initiated. Insulin requirement to regulate hyperglycemia was short-lived. Repeat oral glucose tolerance test five years later was normal. The findings of this patient show that diabetes mellitus can develop at any time during follow-up of cases with proportein convertase 1/3 deficiency especially under GH therapy. Galenos Publishing 2017-09 2017-09-01 /pmc/articles/PMC5596812/ /pubmed/28588004 http://dx.doi.org/10.4274/jcrpe.3986 Text en ©Copyright 2017 by Turkish Pediatric Endocrinology and Diabetes Society The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gönç, E. Nazlı
Özön, Alev
Alikaşifoğlu, Ayfer
Kandemir, Nurgün
Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title_full Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title_fullStr Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title_full_unstemmed Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title_short Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
title_sort long-term follow-up of a case with proprotein convertase 1/3 deficiency: transient diabetes mellitus with intervening diabetic ketoacidosis during growth hormone therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596812/
https://www.ncbi.nlm.nih.gov/pubmed/28588004
http://dx.doi.org/10.4274/jcrpe.3986
work_keys_str_mv AT goncenazlı longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy
AT ozonalev longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy
AT alikasifogluayfer longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy
AT kandemirnurgun longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy